79253207 - XBRANE

Information

• Trademark
• 79253207

• Source

• Serial Number

  79253207

• Registration Number

  6004520

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 12, 2018
  6 years ago

• Registration Date

  March 10, 2020
  4 years ago

• Transaction Date

  July 31, 2020
  4 years ago

• Status Date

  March 10, 2020
  4 years ago

• Published for Opposition Date

  December 24, 2019
  5 years ago

• Location Date

  March 10, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  GARDNER, DAWNA BERYL

• Attorney Docket Number

  008677-0002

  Attorney Name

  Andy I. Corea

  Law Office Assigned Location Code

  M80

• Owners

  • Xbrane Biopharma AB

Case File Statements

• CC0000: The color(s) dark blue and light blue is/are claimed as a feature of the mark.
• DM0000: The mark consists of the stylized light blue and dark blue wording "XBRANE".
• GS0051: Pharmaceutical preparations and medical preparations all for treating cancer, endometriosis, myoma, eye diseases, age related macular degeneration, skin diseases, precocious puberty, vascular diseases, cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, autoimmune diseases, angiogenesis diseases and disorders, genetic conditions, infectious diseases, ocular diseases and disorders, inflammatory diseases and disorders, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, ulcerative colitis, diabetes, diabetic macular edema, diabetic related retinopathy, multiple sclerosis, arthritis, osteoporosis, bone metastasis; generic pharmaceutical preparations and biological pharmaceutical preparations all for treating cancer, endometriosis, myoma, eye diseases, age related macular degeneration, skin diseases, precocious puberty, vascular diseases, cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, autoimmune diseases, angiogenesis diseases and disorders, genetic conditions and infectious diseases; generic pharmaceutical preparations and biological pharmaceutical preparations all for treating ocular diseases and disorders, inflammatory diseases and disorders, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, ulcerative colitis, diabetes, diabetic macular edema, diabetic related retinopathy, multiple sclerosis, arthritis, osteoporosis, bone metastasis; chemotherapeutics; hormones for medical purposes; pharmaceutical agents for treating metabolic disorders; amino acids for medical purposes; pharmaceutical agents for treating immunity disorders; pharmaceutical agents for treating physically caused lesions; antiviral preparations; diagnostic kits consisting primarily of monoclonal antibodies for the diagnosis, treatment and prevention of cancer, endometriosis, myoma, eye diseases, age related macular degeneration, skin diseases, precocious puberty, vascular diseases, cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, autoimmune diseases, angiogenesis diseases and disorders, genetic conditions, infectious diseases; diagnostic kits consisting primarily of monoclonal antibodies for the diagnosis, treatment and prevention of ocular diseases and disorders, inflammatory diseases and disorders, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, ulcerative colitis, diabetes, diabetic macular edema, diabetic related retinopathy, multiple sclerosis, arthritis, osteoporosis and bone metastasis
• GS0101: Surgical apparatus and instruments; injection device for pharmaceuticals; injection syringes; injection needles; medical apparatus, namely, automatic infusion and injection devices for administering drugs to humans
• GS0421: Scientific and medical research and development; pharmaceutical research and development services; research and development services in the fields of biological similar pharmaceuticals, generic drugs, biotechnology, diagnostics and pharmaceuticals; consultancy services relating to the discovery and evaluation of drugs and chemical compounds having diagnostic properties and therapeutic properties; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; diagnostic services in the field of troubleshooting biotechnology and pharmaceutical equipment for scientific research purposes; analyzing biotechnology and pharmaceutical equipment for scientific research purposes; development of new technology for others in the field of biotechnology; medical, pharmaceutical and biotechnological laboratory research services; information, consultancy and advisory services relating to scientific and medical research and development, biotechnological and pharmaceutical research and development and medical equipment research and development

Case File Event Statements

• 7/31/2020 - 4 years ago

  31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 7/11/2020 - 4 years ago

  30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 7/11/2020 - 4 years ago

  29 - FINAL DISPOSITION PROCESSED Type: FIMP

• 6/10/2020 - 4 years ago

  28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 3/10/2020 - 4 years ago

  27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/3/2020 - 5 years ago

  26 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 12/24/2019 - 5 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/24/2019 - 5 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/18/2019 - 5 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/18/2019 - 5 years ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 12/4/2019 - 5 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/19/2019 - 5 years ago

  20 - ASSIGNED TO LIE Type: ALIE

• 11/15/2019 - 5 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/7/2019 - 5 years ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/7/2019 - 5 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/7/2019 - 5 years ago

  16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 7/9/2019 - 5 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 7/9/2019 - 5 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 7/9/2019 - 5 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 6/12/2019 - 5 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/12/2019 - 5 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/12/2019 - 5 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/6/2019 - 5 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 3/20/2019 - 5 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/20/2019 - 5 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/9/2019 - 5 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/8/2019 - 5 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/7/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/5/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/5/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/28/2019 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR